Based on these findings, it is tempting to speculate that silenced expression of HS3ST2 could be compensated with the expression of another isozyme, i. e. HS3ST3B or 4, depending on the molecular signature of cancer cells and/or changes in the tumor environment [17]. This evidence concerns the gene HS3ST3B1 and cancer.